AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
CN
Bio
Professional summary
W. Carter Neild is a Managing Partner at OrbiMed and joined the firm in 2002. He led OrbiMed's expansion into healthcare royalty opportunities and Asia private investments. Before OrbiMed, he was a Director in UBS's Alternative Investments Group and spent four years in the investment management division of First Chicago, now part of J.P. Morgan.
Background
Career, education, and skills
Career history
- OrbiMedManaging Partner2002 – Present
- UBSDirector, Alternative Investments Group
- First ChicagoInvestment Management Division
Education
- University of ChicagoM.B.A. in Finance
- Emory UniversityB.A. in Economics
- Institut d'Etudes Politiques de ParisC.E.P.1991
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.
David Wang
Partner
OrbiMed
OrbiMed Asia Partner focused on Greater China healthcare investments.